New model for conducting clinical trials
Apellis Pharmaceuticals turned to the Optum Digital Research Network (DRN) to help identify participants for a clinical trial of a new drug to treat a rare disease. The DRN shortened the identification and recruitment processes of clinical trial patients.
Optum and Merck collaborative
A new collaborative between Optum® and Merck has created an innovative “Learning Laboratory” to study the impacts of various value-based contracts in different therapeutic areas.
FDA Guidance on Real-World Evidence
Through its real-world data and technology, Optum sits in the perfect spot to partner with life sciences companies and the FDA. Helping to bring therapeutics to patients faster than ever before.